Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Drug Safety|March 23, 2011
Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UKTehreem F Butt, Anthony R Cox, Helen Lewis, et al.
Drug Safety|June 19, 2008
Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysisSara Ormerod, Sarah E McDowell, Jamie J Coleman, et al.
BMJ Case Reports|June 21, 2011
Calciphylaxis associated with widespread pulmonary calcificationTarvinder Singh Dhanjal, Suresh B Babu, Gareth Beevers, et al.
Drug Safety|January 22, 2022
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of PublicityRobin E Ferner, Richard J Stevens, Christopher Anton, et al.
British Journal of Clinical Pharmacology|June 21, 2019
Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50Simon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Drug Safety|October 13, 2012
Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysisTehreem F Butt, Anthony R Cox, Jan R Oyebode, et al.
American Journal of Medical Genetics. Part A|June 4, 2011
Neurofibromatosis 2: a novel risk factor for hypertension?Rachael E Hornigold, John F Golding, Robin E Ferner, et al.
British Journal of Clinical Pharmacology|June 30, 2022
Prescribing direct-acting oral anticoagulants - Mind the evidence gapElizabeth Adeyeye, Carmela Maniero, Emma F Magavern, et al.
BMC Medical Informatics and Decision Making|June 6, 2013
Effects of a computerized feedback intervention on safety performance by junior doctors: results from a randomized mixed method studySabi Redwood, Nothando B Ngwenya, James Hodson, et al.
British Journal of Clinical Pharmacology|June 6, 2020
Are high-cost drug funding mechanisms fit for purpose? A retrospective study of individual funding requests in an NHS tertiary hospitalSonali Sanghvi, Rachel Allen, Steven Cho, et al.
Pageof 8